Pfizer’s COVID-19 vaccine shows promise, many unknowns remain
The results of the Phase-1 trial, announced in August, first through a press release and then through a preprint a
Read More
Vaccines
It makes sense to bring people to the vaccine instead of taking COVID-19 vaccine to people in some settings: Gagandeep Kang
The government recently said it will procure the vaccine and distribute it under a special COVID-19 immunisation programme to certain
Read More
India’s potential participation in COVAX advance market commitment is under way: Trevor Mundel
Trevor Mundel, President of the Global Health Division, Bill & Melinda Gates Foundation, has led the foundation’s efforts to support
Read More
FDA shows spine, rules out COVID-19 vaccines before Presidential election
With at least two months follow-up data likely to be available earliest only by November or December, the guidance essentially
Read More
Human challenge trials will help us design better treatments, vaccines than we can now: Gagandeep Kang
The world’s first human challenge trial for a vaccine against SARS-CoV-2 is set to begin in London in January. Human challenge trials for the SARS-CoV-2 virus have many challenges, including producing a strain that is less virulent, but Dr. Gagandeep Kang says such trials can provide information and help design better vaccines than we can do now with conventional trials.
Read More
Can universal masking be a crude ‘vaccine’?
Universal mask wearing decreases the chance of infection and, if infected, decreases the amount of virus particles (inoculum) a mask-wearer is exposed to thus causing only asymptomatic infection or mild COVID-19 disease.
Read More
Scientists alert Lancet to ‘data inconsistencies’ in the Russian vaccine trial paper
A group of 16 scientists has written an open letter to Dr Richard Horton, editor of The Lancet and authors
Read More
Russia’s coronavirus vaccine is safe, elicits immune responses in Phase-1/2 trials
Russia’s Sputnik V vaccines for novel coronavirus have been found to be safe for a period of 42 days and
Read More
Intranasal vaccination of a coronavirus candidate vaccine prevents infection
A new vaccine candidate construct using chimpanzee adenovirus carrying the full length of novel coronavirus spike protein as a transgene
Read More
Interim results of phase-1-2 trials find inactivated coronavirus vaccine is safe
Interim results of Phase-1 and Phase-2 trials of an inactivated SARS-CoV-2 vaccine carried out in China show that the
Read More
Why Russia’s rushed-up coronavirus vaccine is mired in ethical, safety landmine
Russia registering a vaccine for novel coronavirus even before beginning a Phase-3 trial and promising to begin full-scale production
Read More
T cell memory that cross-reacts with novel coronavirus does not prevent infection, researcher clarifies
The presence of pre-existing T cell memory against four common cold coronaviruses which cross-reacts with novel coronavirus may not
Read More
Is there a case for issuing immunity certificates to COVID-19 recovered people?
While there is a clear case for ‘immunity passports’ with some restrictions for people who have recovered from COVID-19,
Read More